(19)
(11) EP 4 164 653 A1

(12)

(43) Date of publication:
19.04.2023 Bulletin 2023/16

(21) Application number: 21826036.2

(22) Date of filing: 15.06.2021
(51) International Patent Classification (IPC): 
A61K 31/519(2006.01)
C07D 487/20(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 487/22
(86) International application number:
PCT/US2021/037462
(87) International publication number:
WO 2021/257587 (23.12.2021 Gazette 2021/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.06.2020 US 202063039372 P
13.11.2020 US 202017097854
27.04.2021 US 202163180578 P

(71) Applicant: G1 Therapeutics, Inc.
Research Triangle Park, NC 27709 (US)

(72) Inventors:
  • SCHNEIDER, Stephen
    Research Triangle Park, NC 27709 (US)
  • SMITH, Alexander
    Research Triangle Park, NC 27709 (US)
  • WHITE, Hannah, S.
    Research Triangle Park, NC 27709 (US)
  • STRUM, Jay, Copeland
    Hillsborough, NC 27278 (US)
  • MAZUREK, Jaroslaw
    B9030 Mariakerke (BE)
  • WU, Sara
    Research Triangle Park, NC 27709 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF